In the de novo AML group in this study, three patients (#3, #7, and #10) died; all three patients showed DNMT3A mutations and had high PTD copy numbers (estimated to be 17, 8.6, and 9.7, respectively), although the sample size is small. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.